Bone augmentation by bone marrow mesenchymal stem cells cultured in three-dimensional biodegradable polymer scaffolds

2009 ◽  
Vol 91A (2) ◽  
pp. 428-435 ◽  
Author(s):  
Toshimitsu Tanaka ◽  
Motohiro Hirose ◽  
Noriko Kotobuki ◽  
Mika Tadokoro ◽  
Hajime Ohgushi ◽  
...  
2019 ◽  
Vol 69 (6) ◽  
pp. 373-380 ◽  
Author(s):  
Hammed Tanimowo Aiyelabegan ◽  
Malihe Ebadi ◽  
Gholam Ali Kardar ◽  
Nasrin Lotfibakhshaiesh ◽  
Farid Abedin Dorkoosh ◽  
...  

2013 ◽  
Vol 24 (15) ◽  
pp. 1794-1813 ◽  
Author(s):  
Paschalia M. Mountziaris ◽  
E. Dennis Lehman ◽  
Ioannis Mountziaris ◽  
David C. Sing ◽  
F. Kurtis Kasper ◽  
...  

2016 ◽  
Vol 26 (2) ◽  
pp. 173-173
Author(s):  
A. V. Kisil ◽  
◽  
V. V. Kiroshka ◽  
Tatyana P. Bondarenko ◽  
V. A. Petrova ◽  
...  

2020 ◽  
Vol 15 ◽  
pp. 210-215
Author(s):  
Suguru Nitta ◽  
Masaharu Hisasue ◽  
Yu Horiguchi ◽  
Yoko Yamada ◽  
Kaoruko Kikuchi ◽  
...  

2015 ◽  
Vol 77 (25) ◽  
Author(s):  
Rozlin Abdul Rahman ◽  
Norhamiza Mohamad Sukri ◽  
Noorhidayah Md Nazir ◽  
Muhammad Aa’zamuddin Ahmad Radzi ◽  
Ahmad Hafiz Zulkifly ◽  
...  

Articular cartilage has poor repair capacity due to its avascular and aneural properties and has relatively few cells. This study investigated the ability of autologous implantation approach using three dimensional (3D) constructs engineered from bone marrow mesenchymal stem cells (BMSCs) seeded on poly(lactic-co-glycolic acid) (PLGA) with or without fibrin as cells carrier for the repair of osteochondral defect in rabbit model. The engineered 3D constructs – PLGA/Fibrin/BMSCs and PLGA/BMSCs – were cultured for 3 weeks in vitro and implanted autologously to the osteochondral defect created in the rabbit knee. The in vivo constructs were harvested and evaluated by means of gross observation, histology assessment, gene expression study, sulphated glycosaminoglycan (sGAG) production assay and biomechanical evaluation at 6 and 12 weeks post implantation. The results showed that the osteochondral defects treated with the PLGA/Fibrin/BMSCs constructs exhibited better repairment, more cartilaginous extracellular matrix, higher sGAG production, superior compressive strength and more intense expression of chondrogenic marker genes than the PLGA/BMSCs group. This study suggested that the PLGA/Fibrin/BMSCs has the potential to treat osteochondral defect and may be presented as a viable therapeutic option for those who would be in need from the life-extending benefits of tissue replacement or repair.


Sign in / Sign up

Export Citation Format

Share Document